|
1
|
Bevan S: Spondyloarthropathy and Work. A
Review of UK Evidence. The Work Foundation, London, 2010.
|
|
2
|
Dougados M and Baeten D:
Spondyloarthritis. Lancet. 377:2127–2137. 2011.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Bakland G and Nossent HC: Epidemiology of
spondyloarthritis: A review. Curr Rheumatol Rep.
15(351)2013.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Arumugam R and McHugh NJ: Mortality and
causes of death in psoriatic arthritis. J Rheumatol Suppl.
89:32–35. 2012.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Bakland G, Gran JT and Nossent JC:
Increased mortality in ankylosing spondylitis is related to disease
activity. Ann Rheum Dis. 70:1921–1925. 2011.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Braun J, van den Berg R, Baraliakos X,
Boehm H, Burgos-Vargas R, Collantes-Estevez E, Dagfinrud H,
Dijkmans B, Dougados M, Emery P, et al: 2010 update of the
ASAS/EULAR recommendations for the management of ankylosing
spondylitis. Ann Rheum Dis. 70:896–904. 2011.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Gossec L, Smolen JS, Gaujoux-Viala C, Ash
Z, Marzo-Ortega H, van der Heijde D, FitzGerald O, Aletaha D,
Balint P, Boumpas D, et al: European league against rheumatism
recommendations for the management of psoriatic arthritis with
pharmacological therapies. Ann Rheum Dis. 71:4–12. 2012.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Palazzi C, Olivieri I, D'Amico E, Pennese
E and Petricca A: Management of reactive arthritis. Expert Opin
Pharmacother. 5:61–70. 2004.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Kwiatkowska B and Filipowicz-Sosnowska A:
Reactive arthritis. Pol Arch Med Wewn. 119:60–65. 2009.PubMed/NCBI
|
|
10
|
Orchard TR: Management of arthritis in
patients with inflammatory bowel disease. Gastroenterol Hepatol
(NY). 8:327–329. 2012.PubMed/NCBI
|
|
11
|
Arvikar SL and Fisher MC: Inflammatory
bowel disease associated arthropathy. Curr Rev Musculoskelet Med.
4:123–131. 2011.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Smolen JS, Braun J, Dougados M, Emery P,
Fitzgerald O, Helliwell P, Kavanaugh A, Kvien TK, Landewé R, Luger
T, et al: Treating spondyloarthritis, including ankylosing
spondylitis and psoriatic arthritis, to target: Recommendations of
an international task force. Ann Rheum Dis. 73:6–16.
2014.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Braun J, Kiltz U, Baraliakos X and van der
Heijde D: Optimisation of rheumatology assessments - the actual
situation in axial spondyloarthritis including ankylosing
spondylitis. Clin Exp Rheumatol. 32 (Suppl 85):S96–S104.
2014.PubMed/NCBI
|
|
14
|
Salaffi F, Ciapetti A, Carotti M,
Gasparini S and Gutierrez M: Disease activity in psoriatic
arthritis: Comparison of the discriminative capacity and construct
validity of six composite indices in a real world. BioMed Res Int.
2014(528105)2014.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Eberl G, Studnicka-Benke A, Hitzelhammer
H, Gschnait F and Smolen JS: Development of a disease activity
index for the assessment of reactive arthritis (DAREA).
Rheumatology (Oxford). 39:148–155. 2000.PubMed/NCBI View Article : Google Scholar
|
|
16
|
van der Heijde D, Lie E, Kvien TK, Sieper
J, Van den Bosch F, Listing J, Braun J and Landewé R: Assessment of
SpondyloArthritis international Society (ASAS): ASDAS, a highly
discriminatory ASAS-endorsed disease activity score in patients
with ankylosing spondylitis. Ann Rheum Dis. 68:1811–1818.
2009.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Helliwell PS, FitzGerald O, Fransen J,
Gladman DD, Kreuger GG, Callis-Duffin K, McHugh N, Mease PJ, Strand
V, Waxman R, et al: The development of candidate composite disease
activity and responder indices for psoriatic arthritis (GRACE
project). Ann Rheum Dis. 72:986–991. 2013.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Zochling J: Measures of symptoms and
disease status in ankylosing spondylitis: Ankylosing Spondylitis
Disease Activity Score (ASDAS), Ankylosing Spondylitis Quality of
Life Scale (ASQoL), Bath Ankylosing Spondylitis Disease Activity
Index (BASDAI), Bath Ankylosing Spondylitis Functional Index
(BASFI), Bath Ankylosing Spondylitis Global Score (BAS-G), Bath
Ankylosing Spondylitis Metrology Index (BASMI), Dougados Functional
Index (DFI), and Health Assessment Questionnaire for the
Spondylarthropathies (HAQ-S). Arthritis Care Res (Hoboken). 63
(Suppl 11):S47–S58. 2011.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Gladman DD, Mease PJ, Healy P, Helliwell
PS, Fitzgerald O, Cauli A, Lubrano E, Krueger GG, van der Heijde D,
Veale DJ, et al: Outcome measures in psoriatic arthritis. J
Rheumatol. 34:1159–1166. 2007.PubMed/NCBI
|
|
20
|
Rohekar S and Pope J: Assessment of work
disability in seronegative spondyloarthritis. Clin Exp Rheumatol.
28:35–40. 2010.PubMed/NCBI
|
|
21
|
Daltroy LH, Larson MG, Roberts NW and
Liang MH: A modification of the Health Assessment Questionnaire for
the spondyloarthropathies. J Rheumatol. 17:946–950. 1990.PubMed/NCBI
|
|
22
|
Bruce B and Fries JF: The Health
Assessment Questionnaire (HAQ). Clin Exp Rheumatol. 23 (Suppl
39):S14–S18. 2005.PubMed/NCBI
|
|
23
|
Kotsis K, Voulgari PV, Drosos AA, Carvalho
AF and Hyphantis T: Health-related quality of life in patients with
ankylosing spondylitis: A comprehensive review. Expert Rev
Pharmacoecon Outcomes Res. 14:857–872. 2014.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Kifley A, Heller GZ, Beath KJ, Bulger D,
Ma J and Gebski V: Multilevel latent variable models for global
health-related quality of life assessment. Stat Med. 31:1249–1264.
2012.PubMed/NCBI View
Article : Google Scholar
|
|
25
|
Machado P and van der Heijde D: How to
measure disease activity in axial spondyloarthritis? Curr Opin
Rheumatol. 23:339–345. 2011.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Singh HJ, Nimarpreet K, Ashima Das S,
Kumar A and Prakash S: Study of bone mineral density in patients
with ankylosing spondylitis. J Clin Diagn Res. 7:2832–2835.
2013.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Caruntu C, Boda D, Dumitrascu G,
Constantin C and Neagu M: Proteomics focusing on immune markers in
psoriatic arthritis. Biomarkers Med. 9:513–528. 2015.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Berthelot JM, Le Goff B and Maugars Y: The
Hawthorne effect: Stronger than the placebo effect? Joint Bone
Spine. 78:335–336. 2011.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Landewé R, Dougados M, Mielants H, van der
Tempel H and van der Heijde D: Physical function in ankylosing
spondylitis is independently determined by both disease activity
and radiographic damage of the spine. Ann Rheum Dis. 68:863–867.
2009.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Tillett W, Shaddick G, Askari A, Cooper A,
Creamer P, Clunie G, Helliwell PS, Kay L, Korendowych E, Lane S, et
al: Factors influencing work disability in psoriatic arthritis:
First results from a large UK multicentre study. Rheumatology
(Oxford). 54:157–162. 2015.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Boda D, Negrei C, Nicolescu F and Badalau
C: Assessment of some oxidative stress parameters in methotrexate
treated psoriasis patients. Farmacia. 62:704–710. 2014.
|
|
32
|
Weiss A, Song IH, Haibel H, Listing J and
Sieper J: Good correlation between changes in objective and
subjective signs of inflammation in short- but not long-diseased
patients with axial spondyloarthritis treated with tumor necrosis
factor-blockers. Arthritis Res Ther. 16(R35)2014.PubMed/NCBI View
Article : Google Scholar
|
|
33
|
Saber TP, Ng CT, Renard G, Lynch BM,
Pontifex E, Walsh CA, Grier A, Molloy M, Bresnihan B, Fitzgerald O,
et al: Remission in psoriatic arthritis: Is it possible and how can
it be predicted? Arthritis Res Ther. 12(R94)2010.PubMed/NCBI View
Article : Google Scholar
|
|
34
|
O'Dwyer T, O'Shea F and Wilson F: Exercise
therapy for spondyloarthritis: A systematic review. Rheumatol Int.
34:887–902. 2014.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Mesquita C, Lopes S, Excelsa Moreira M,
Lopes P, Carneiro A, Silva D, Neves I, Araújo F and Vitorino A:
A2.8 Effect of home exercise program in quality of life in patients
with ankylosing spondylitis. Ann Rheum Dis. 73 (Suppl
1)(A41)2014.
|
|
36
|
van den Berg R, Baraliakos X, Braun J and
van der Heijde D: First update of the current evidence for the
management of ankylosing spondylitis with non-pharmacological
treatment and non-biologic drugs: A systematic literature review
for the ASAS/EULAR management recommendations in ankylosing
spondylitis. Rheumatology (Oxford). 51:1388–1396. 2012.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Husted JA, Tom BD, Farewell VT, Schentag
CT and Gladman DD: A longitudinal study of the effect of disease
activity and clinical damage on physical function over the course
of psoriatic arthritis: Does the effect change over time? Arthritis
Rheum. 56:840–849. 2007.PubMed/NCBI View Article : Google Scholar
|
